Russia is developing what officials have described as a “vaccine against aging,” a gene therapy drug aimed at slowing cellular aging by blocking a receptor linked to age-related changes in the body, the deputy science minister said Thursday
Denis Sekirinsky, Russia’s deputy science and higher education minister, said the experimental treatment would target the RAGE receptor, which he said triggers cellular aging when activated
“The RAGE gene is a receptor whose activation launches the aging of the cell. Blocking this gene, on the contrary, can prolong its youth,” Sekirinsky said at a healthy longevity conference in the Volga city of Saransk, according to the state-run TASS news agency
He said the goal was to create “the world’s first gene therapy drug” specifically designed to block the receptor
The project is being developed by the Institute of Aging Biology and Medicine and is part of Russia’s broader push to expand domestic biotechnology research as the country faces demographic decline and a rapidly aging population
Russian officials have increasingly framed longevity research as both a public health priority and a matter of national importance, with the Kremlin promoting scientific programs aimed at extending healthy life expectancy
Deputy Prime Minister Tatyana Golikova previously said Russia planned to begin producing an anti-aging drug between 2028 and 2030
“What some time ago we could describe as an incredible future is now becoming reality,” Golikova said earlier
The work is being carried out under the New Technologies for Health Preservation National Project launched in 2025 at the instruction of President Vladimir Putin
The program has a budget of more than 2 trillion rubles ($26.4 billion)
A Meduza that the project stemmed from what they described as an “obsessive idea” of Mikhail Kovalchuk, a longtime Putin ally and head of the Kurchatov Institute, “who dreams of eternal life and the ‘genome of the Russian person’.”
Kovalchuk also oversees a federal genetics development program involving Putin’s alleged eldest daughter, endocrinologist Maria Vorontsova
Putin is 73, and many of Russia’s top officials are of a similar age. Average life expectancy for Russian men is around 67 years, according to official statistics
Read this article in Russian at The Moscow Times’ Russian service
Read more about:
Science
, Vaccine
A Message from The Moscow Times:
Dear readers
We are facing unprecedented challenges. Russia’s Prosecutor General’s Office has designated The Moscow Times as an “undesirable” organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a “foreign agent.”
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work “discredits the decisions of the Russian leadership.” We see things differently: we strive to provide accurate, unbiased reporting on Russia
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It’s quick to set up, and every contribution makes a significant impact
Once
Monthly
Annual
Continue
Not ready to support today? Remind me later.
×
Remind me next month
Remind me
Thank you! Your reminder is set.
We will send you one reminder email a month from now. For details on the personal data we collect and how it is used, please see our Privacy Policy.
Vaccine hesitancy in Uzbekistan is high, bred by social media conspiracies that seem credible in a country without accountable authorities.
Sputnik Light “demonstrated 79.4% efficacy” compared to 91.6% for the two-shot Sputnik V, its developers claim.
The makers of Russia’s third approved Covid-19 vaccine said volunteers who took a live polio vaccine saw “sharp reduction” in coronavirus incidence.
Climate change, virtual reality and a masterclass on eating insects are just some of the highlights of the upcoming 360° Science and Technology Film Festival…
